Blood sugar loss may trigger Alzheimer’s: study
LONDON (Reuters) - A slow, chronic reduction of blood sugar to the brain could trigger some forms of Alzheimer’s disease, U.S. researchers said on Wednesday.
The study of human and mice brains suggests a reduction of blood flow deprives energy to the brain, setting off a process that ultimately produces the sticky clumps of protein researchers believe is a cause of the disease, they said.
The finding could lead to strategies such as exercise, reducing cholesterol and managing blood pressure to keep Alzheimer’s at bay, Robert Vassar and colleagues at Northwestern University’s Feinberg School of Medicine in Chicago reported.
“This finding is significant because it suggests that improving blood flow to the brain might be an effective therapeutic approach to prevent or treat Alzheimer’s,” Vassar, who led the study, said in a statement.
“If people start early enough, maybe they can dodge the bullet.”
Alzheimer’s disease is incurable and is the most common form of dementia among older people. It affects the regions of the brain involving thought, memory and language.
While the most advanced drugs have focused on removing clumps of beta amyloid protein that forms plaques in the brain, researchers also are looking at therapies to address the toxic tangles caused by an abnormal build-up of the protein tau.
Vassar and colleagues analyzed human and mice brains to discover that a protein called elF2alpha is altered when the brain does not get enough energy. This boosts production of an enzyme that in turn flips a switch to produce the sticky protein clumps.
The finding published in the journal Neuron could lead to drugs designed to block the elF2alpha production that begins the formation of the protein clumps, also known as amyloid plaques, Vassar added.
“What we are talking about is a slow, insidious process over many years,” he said. “It’s so mild (people) don’t even notice it, but it has an effect over time because it’s producing a chronic reduction in the blood flow.”
(Reporting by Michael Kahn; Editing by Michael Roddy)
--------------------------------------------------------------------------------------------Related Posts:
By Will Dunham WASHINGTON (Reuters) - Brain scans of people with an abnormality that is a hallmark of Alzheimer’s disease are strengthening the notion that greater education levels somehow protect against this common form of dementia. People with more education did better on memory and problem solving tests than others with similar amounts of brain plaques related
Full Post: Education blunts effects of Alzheimer’s: study
--------------------------------------------------------------------------------------------
NEW YORK (Reuters Health) - Low levels of cystatin C — a blood protein commonly used as a measure of kidney function — may be a risk factor for the development of Alzheimer’s disease in elderly men, researchers report. Cystatin C is produced by nearly all human cells and available in all body fluids. During the
Full Post: Blood protein tied to Alzheimer’s disease risk
--------------------------------------------------------------------------------------------
LONDON (Reuters) - Mice fed junk food for nine months showed signs of developing the abnormal brain tangles strongly associated with Alzheimer’s disease, a Swedish researcher said on Friday. The findings, which come from a series of published papers by a researcher at Sweden’s Karolinska Institutet, show how a diet rich in fat, sugar and cholesterol
Full Post: Research on mice links fast food to Alzheimer’s
--------------------------------------------------------------------------------------------
By Amy Norton NEW YORK (Reuters Health) - Older adults who smoke may face an elevated risk of developing Alzheimer’s disease, a new study suggests. In an analysis of two dozen previous studies, UK researchers found that older adults who currently smoked were at greater risk of Alzheimer’s than were non-smokers. When the results of the studies
Full Post: Alzheimer’s risk upped in senior smokers
--------------------------------------------------------------------------------------------
By Will Dunham WASHINGTON (Reuters) - High doses of B vitamins failed to slow cognitive decline in people with Alzheimer’s disease, dashing the hopes for a new weapon against the fatal, mind-robbing ailment, U.S. researchers said on Tuesday. Experts had viewed B vitamins as a potential way to lower the risk of Alzheimer’s disease or slow its
Full Post: B vitamins fail in U.S. Alzheimer’s disease study